Detalhe da pesquisa
1.
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.
Immunity
; 54(9): 2042-2056.e8, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407391
2.
Targeting Degradation of the Transcription Factor C/EBPß Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in Macrophages.
Immunity
; 51(3): 522-534.e7, 2019 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471107
3.
The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.
Immunity
; 54(10): 2433-2435, 2021 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644559
4.
TRIB3 Interacts With ß-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Gastroenterology
; 156(3): 708-721.e15, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365932
5.
Autophagy: a new pathway for traditional Chinese medicine.
J Asian Nat Prod Res
; 20(1): 14-26, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28954538
6.
Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy.
Front Pharmacol
; 14: 1118017, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37124193
7.
External Ba2+ block of the two-pore domain potassium channel TREK-1 defines conformational transition in its selectivity filter.
J Biol Chem
; 286(46): 39813-22, 2011 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21965685
8.
Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.
Sci Transl Med
; 13(586)2021 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762435
9.
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target.
Nat Commun
; 11(1): 3660, 2020 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32694521
10.
Disruption of the EGFR-SQSTM1 interaction by a stapled peptide suppresses lung cancer via activating autophagy and inhibiting EGFR signaling.
Cancer Lett
; 474: 23-35, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31931029
11.
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
Nat Commun
; 11(1): 6316, 2020 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33298911
12.
Disrupting the TRIB3-SQSTM1 interaction reduces liver fibrosis by restoring autophagy and suppressing exosome-mediated HSC activation.
Autophagy
; 16(5): 782-796, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31286822
13.
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription.
Nat Commun
; 10(1): 5720, 2019 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31844113
14.
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
Cancer Cell
; 31(5): 697-710.e7, 2017 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28486108
15.
BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Cancer Lett
; 365(2): 190-200, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26049022